Explore more publications!
US Healthcare Journal
Got News to Share?

Press Releases

SleepScriptMD Offers Fast, Flexible Sleep Care with Same-Day Prescription Approval Across the U.S.
2 hours ago

SleepScriptMD Offers Fast, Flexible Sleep Care with Same-Day Prescription Approval Across the U.S.

Neutral EIN Presswire
U.S. Retail Pharmacy Market to Reach US$ 901.4 Bn by 2032 | Persistence Market Research
5 hours ago

U.S. Retail Pharmacy Market to Reach US$ 901.4 Bn by 2032 | Persistence Market Research

Neutral EIN Presswire
Visit Philadelphia and TED Announce Programming and Initial Speaker Lineup for “Founding Futures” Ahead of America’s 250th
4 hours ago

Visit Philadelphia and TED Announce Programming and Initial Speaker Lineup for “Founding Futures” Ahead of America’s 250th

Neutral Visit Philly - Pennsylvania
Owner: Greater Philadelphia Tourism Marketing Corporation

Visit Philly

Neutral
Owned By Greater Philadelphia Tourism Marketing Corporation (Non-profit, Angela Val CEO)
Year Founded 1996
Website https://www.visitphilly.com/
Domain Registration Year 1999
Access Type open
Publication Location United States, Pennsylvania, Philadelphia
Owner Country United States

We welcome your feedback!
If you have comments or corrections, let us know.

Utah measles outbreak grows to 486 cases as U.S. total approaches 1,600 
15 hours ago

Utah measles outbreak grows to 486 cases as U.S. total approaches 1,600 

Neutral American Hospital Association
Brioworkx Expands into U.S. Market with New Office Supporting Publishing and Digital Transformation Clients
18 hours ago

Brioworkx Expands into U.S. Market with New Office Supporting Publishing and Digital Transformation Clients

Neutral EIN Presswire
LIS Technologies Inc. Announces Fifth Consecutive Oversubscribed Funding Round of $7.1 Million, Totaling over $71 Million to Revitalize the Only U.S.-Origin, Patented Laser Uranium Enrichment Technology to Support the Nuclear Fuel Cycle
Mar. 31, 2026

LIS Technologies Inc. Announces Fifth Consecutive Oversubscribed Funding Round of $7.1 Million, Totaling over $71 Million to Revitalize the Only U.S.-Origin, Patented Laser Uranium Enrichment Technology to Support the Nuclear Fuel Cycle

Indeterminate GlobeNewswire, Inc.
i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD
Mar. 31, 2026

i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD

Neutral EIN Presswire
Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)
Mar. 31, 2026

Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)

Indeterminate GlobeNewswire, Inc.
Spartan Medical and Headsafe US Inc. Announce U.S. Partnership to Expand Access to Objective Concussion Assessment
Mar. 31, 2026

Spartan Medical and Headsafe US Inc. Announce U.S. Partnership to Expand Access to Objective Concussion Assessment

Neutral EIN Presswire
PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics
Mar. 31, 2026

PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics

Indeterminate GlobeNewswire, Inc.
U.S. Thermal Management Technologies Market to Reach US$ 9.8 Billion by 2033, Growing at a 9.4% CAGR
Mar. 31, 2026

U.S. Thermal Management Technologies Market to Reach US$ 9.8 Billion by 2033, Growing at a 9.4% CAGR

Neutral EIN Presswire
Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation
12 hours ago

Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation

Indeterminate GlobeNewswire, Inc.
Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1
Mar. 31, 2026

Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1

Indeterminate GlobeNewswire, Inc.
Medela Voted #1 Most Trusted Breast Pump Brand in the U.S., Canada, and UK for 2026; Pump In Style® Pro Named Best New Product
Mar. 31, 2026

Medela Voted #1 Most Trusted Breast Pump Brand in the U.S., Canada, and UK for 2026; Pump In Style® Pro Named Best New Product

Indeterminate GlobeNewswire, Inc.
Housing Insecurity Emerges as Most Pressing Need Across the U.S., New 211 Data Shows
Mar. 31, 2026

Housing Insecurity Emerges as Most Pressing Need Across the U.S., New 211 Data Shows

Indeterminate GlobeNewswire, Inc.
Circana Research Reveals U.S. Private Label CPG Sales Reach $330 Billion
Mar. 31, 2026

Circana Research Reveals U.S. Private Label CPG Sales Reach $330 Billion

Indeterminate GlobeNewswire, Inc.
Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone
Mar. 31, 2026

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

Indeterminate GlobeNewswire, Inc.
Iantrek Advances New AlloSpan™ Canal into U.S. Site Evaluations, Expanding Its Bio-Interventional Platform
Mar. 31, 2026

Iantrek Advances New AlloSpan™ Canal into U.S. Site Evaluations, Expanding Its Bio-Interventional Platform

Indeterminate GlobeNewswire, Inc.
YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States
Mar. 31, 2026

YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States

Indeterminate GlobeNewswire, Inc.

Indeterminate
Pseudo-journalism warning Pseudo-journalism: 0
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions